Their MHC independence and the presence of combined NKG2D and γδ TCR-facilitated tumor recognition endows the γδ T cells with natural antitumor effects and the potential to overcome key immune evasion mechanisms of GBM [14,24]. The gene discussed is KLRK1; the disease is glioblastoma.